About Intervene
Intervene is a company based in Derby (United Kingdom) founded in 2003. Intervene has raised $37.59 million across 6 funding rounds from investors including Boston Scientific, Treo Ventures and RiverVest Venture Partners. The company has 11 employees as of December 31, 2022. Intervene offers products and services including Recana TM. Intervene operates in a competitive market with competitors including Tactile Medical, enVVeno Medical, Veniti, Sky Medical Technology and DeVoro Medical, among others.
- Headquarter Derby, United Kingdom
- Employees 11 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Intervene, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$37.59 M (USD)
in 6 rounds
-
Latest Funding Round
$13 M (USD), Series B
Oct 07, 2024
-
Investors
Boston Scientific
& 7 more
-
Employee Count
11
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Intervene
Intervene offers a comprehensive portfolio of products and services, including Recana TM.
Engineered to de-bulk and recanalize chronic venous occlusions.
People of Intervene
Unlock access to complete
Unlock access to complete
Funding Insights of Intervene
Intervene has successfully raised a total of $37.59M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $13 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Intervene
Intervene has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, Treo Ventures and RiverVest Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on breakthrough healthcare solutions.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Private investments are managed for institutional investors globally.
|
Locked | Locked | Locked |
Investor details for Intervene
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Intervene
Investment portfolio details for Intervene
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Intervene
Detailed financials for Intervene
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Intervene Comparisons
Peer comparison for Intervene
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Intervene
Intervene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tactile Medical, enVVeno Medical, Veniti, Sky Medical Technology and DeVoro Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Home therapy devices for lymphedema and venous ulcers are provided.
|
|
| Locked | Locked | Locked |
Developer of medical device for the the treatment of venous diseases
|
|
| Locked | Locked | Locked |
A self-expanding stent system for chronic venous disease is developed.
|
|
| Locked | Locked | Locked |
Electro-stimulation devices are manufactured for deep vein thrombosis treatment.
|
|
| Locked | Locked | Locked |
Medical devices for treating cardiac diseases are developed.
|
Detailed competitors of Intervene
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Intervene
Complete news archive for Intervene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Intervene
Intervene was founded in 2003 and raised its 1st funding round 6 years after it was founded.
Intervene is headquartered in Derby, United Kingdom.
Intervene is a funded company, having raised a total of $37.59M across 6 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Intervene is 11.
InterVene was founded in 2003 and is based in Derby, United Kingdom. Medical devices are developed by the company within the healthcare sector, focusing on severe venous disease in the legs. A non-implantable, catheter-based approach is utilized to form new vein valves from native tissue, addressing chronic venous insufficiency. This enables blood to be pumped efficiently from the legs to the heart, shifting care from ongoing management to targeted intervention.
Intervene's top competitors include Tactile Medical, enVVeno Medical and Sky Medical Technology.
Intervene offers Recana TM.
Intervene has 8 investors. Key investors include Boston Scientific, Treo Ventures, RiverVest Venture Partners, American Century Private Investments, and Correlation Ventures.